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Abstract
Background: In recent times, emerging and re-emerging infectious diseases are posing a public health threat in
developing countries, and vigilant surveillance is necessary to prepare against these threats. Analyses of multi-year
comprehensive infectious disease syndrome data are required in Mongolia, but have not been conducted till date.
This study aimed to describe the trends in the incidence of infectious disease syndromes in Mongolia during
2009–2017 using a nationwide syndrome surveillance system for infectious diseases established in 2009.
Methods: We analyzed time trends using monthly data on the incidence of infectious disease syndromes such as
acute fever with rash (AFR), acute fever with vesicular rash (AFVR), acute jaundice (AJ), acute watery diarrhea (AWD),
acute bloody diarrhea (ABD), foodborne disease (FD) and nosocomial infection (NI) reported from January 1, 2009
to December 31, 2017. Time series forecasting models based on the data up to 2017 estimated the future trends in
the incidence of syndromes up to December 2020.
Results: During the study, the overall prevalence of infectious disease syndromes was 71.8/10,000 population
nationwide. The average number of reported infectious disease syndromes was 14,519 (5229-55,132) per year. The
major types were AFR (38.7%), AFVR (31.7%), AJ (13.9%), ABD (10.2%), and AWD (1.8%), accounting for 96.4% of all
reported syndromes. The most prevalent syndromes were AJ between 2009 and 2012 (59.5–48.7%), AFVR between
2013 and 2014 (54.5–59%), AFR between 2015 and 2016 (67.6–65.9%), and AFVR in 2017 (62.2%). There were
increases in the prevalence of AFR, with the monthly number of cases being 37.7 ± 6.1 during 2015–2016; this
could be related to the measles outbreak in Mongolia during that period. The AFVR incidence rate showed winter’s
multiplicative seasonal fluctuations with a peak of 10.6 ± 2 cases per 10,000 population in 2017. AJ outbreaks were
identified in 2010, 2011, and 2012, and these could be associated with hepatitis A outbreaks. Prospective time series
forecasting showed increasing trends in the rates of AFVR and ABD.
Conclusions: The evidence-based method for infectious disease syndromes was useful in gaining an
understanding of the current situation, and predicting the future trends of various infectious diseases in Mongolia.
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Background
In the last two decades, although the burden associated
with communicable diseases has been reducing
through deliberated efforts, worldwide, emerging and
re-emerging infectious diseases are still public health
threats in developing countries due to globalization.
There is a need for constant readiness and prepared-
ness to deal with infectious disease outbreaks includ-
ing emerging and re-emerging infectious disease
threats.
Public health risks can be detected using the syn-
dromic surveillance system (SSS) that includes event-
based surveillance. The SSS has been implemented since
the 1990s and its initial purpose was bioterrorism detec-
tion. In the United States (US), SSS use became wide-
spread in early 2000 [1, 2]. The Centers for Diseases
Control and Prevention defined syndromic surveillance
(SS) as “surveillance using health-related data that
precede diagnosis and signal a sufficient probability of a
case or an outbreak to warrant further public health
response” [3]. Surveillance is the ongoing systematic
collection, analysis, interpretation, and application of
real-time indicators that allows for the detection of
diseases before they would otherwise be identified by
public health authorities. SS in public health surveillance
emphasizes the use of near real-time, pre-diagnostic data
and statistical tools to detect and characterize unusual
activity for further public health investigation. The goal
of syndrome surveillance is the routine gathering of
electronic health data and earlier anomaly detection of
epidemics, allowing for a timelier public health response
utilizing pre-diagnostic data sources than is possible
using conventional surveillance methods, and the moni-
toring of illness progression in a population [1, 2, 4–7].
SS offers superior timeliness and flexibility compared to
diagnosis-based surveillance. However, as SS is a
relatively new approach, there is still a lack of clarity on
its added value.
Mongolia has a comprehensive surveillance system for
infectious disease (ID) consisting of a national indicator-
based, syndromic, event-based, and many disease-spe-
cific surveillance systems managed by both the National
Center for Communicable Diseases (NCCD) and Na-
tional Center for Zoonotic Diseases. There are 55 types
of notifiable infectious diseases. Surveillance data from
each system are regularly reported, with most being
shared at weekly inter-sector surveillance meetings, and
distributed through the NCCD email distribution list
and published on the NCCD website.
Mongolian health services are provided at primary,
secondary and tertiary health care facilities across two
administrative divisions (the capital and the provinces).
The Mongolian health system is heavily a hospital-ori-
ented system. Hence, any disease’s information system in
spans three levels: all family health centers at the pri-
mary level inform health centers in sub-provinces and
public health centers in nine districts at the secondary
level nationwide. Secondary information flows from
health centers in 329 sub-provinces, and public health
centers and general hospitals in districts report to health
departments in 21 provinces and in the capital city.
Health care facilities at the secondary level report to the
NCCD and National Center for Zoonotic Diseases.
The Mongolian SSS for infectious diseases was estab-
lished under the Early Warning and Response (EWAR)
unit of the Department of Surveillance and Prevention
of Infectious Disease at the NCCD for the early detec-
tion of public health threats and outbreaks, for tracking
infectious disease syndromes, and for promptly respond-
ing to events if necessary nationwide. It was initially
piloted in three provinces in 2007 and then expanded
throughout the entire country, including all 21 provinces
and nine districts in the capital city for 2 years until
2009. The SSS consists of case-based surveillance and
was integrated with an event-based surveillance system
in 2010. Surveillance units work in health centers, public
health centers, and health departments in all provinces
and districts in the capital city at the primary and sec-
ondary levels, and the national surveillance unit for SSS
works under the EWAR unit at the NCCD. The SSS in
the EWAR unit also has three reporting levels similar to
the information system for other infectious diseases.
Physicians and health workers in all 1681 family health
centers at the primary level receive data on patient visits,
report diagnoses of the patients, and electronically in-
form 363 Health centers in sub-provinces and districts
at the secondary level via specialized information forms
for ID syndromes according to case definitions for ID
syndromes, suspected cases, and special events every
Monday. Surveillance units at the secondary level receive
this information and combine, analyze the data, and
report to tertiary centers.
SSS collects data on infectious disease syndrome type,
reporting date, demographic information, onset of symp-
toms, admission date, and previous diagnosis of every
suspected case. The health centers in sub-provinces and
districts inform health departments in the 21 provinces
and the capital city and electronically transmit reports
via EWAR 2.0 software every Tuesday to secondary level
surveillances unit for infectious disease syndrome. The
tertiary level units of the EWAR unit combine data from
the EWAR 2.0 software, conduct descriptive data ana-
lyses, develop conclusions and responses in accordance
with the conditions, and send feedback on the ID
syndromes, suspected cases, and special events to all
reporting health facilities at the primary and secondary
level, as well as other related organizations, including
the Ministry of Health (MoH), every Thursday via email.
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For some reports, such as those on foodborne diseases
(FDs), reporting within 2–24 h by calling is required.
Weekly feedback from descriptive analysis at the tertiary
level includes only information on the numbers of each
ID syndrome, suspected cases, and special events by
province, district, and age group.
Case definitions of 22 ID syndromes, suspected cases
and special events have been standardized and approved
by order No. 152, 2010 of the Health Minister. The sub-
ject of the SSS in the EWAR unit includes 11 infectious
disease syndromes: acute flaccid paralysis (AFP), acute
fever with rash (AFR), acute fever with vesicular rash
(AFVR), acute jaundice (AJ), acute watery diarrhea
(AWD), acute bloody diarrhea (ABD), acute respiratory
infection (ARI), influenza and influenza-like illness (ILI),
acute lower respiratory infection (ALRI), acute
hemorrhagic syndrome (AHS), acute neurologic syndrome
(ANS); seven suspected cases: tetanus, neonatal tetanus,
pertussis, diphtheria, anthrax, plague and rabies; and four
special events: FDs, nosocomial infections (NIs), adverse
events following immunization and unexplained clusters
of health events.
Currently, large amounts of infectious disease data are
routinely collected by laboratories, healthcare providers
and government agencies in an effort to increase the un-
derstanding of their evolution and prevent, detect, and
manage infectious disease outbreaks. Due to the emer-
gence and re-emergence of infectious diseases with pan-
demic potential, over the past decade, there has been a
surge in interest on the associated analysis and statistical
methods. This increase in interest has given rise to new
methodological work, ranging across the spectrum of
statistical methods for the early detection of infectious
disease outbreaks. Therefore, there is an urgent need to
monitor and predict these syndromes for effective out-
break control. In this context, one-step-ahead forecasts,
especially when syndrome information is incorporated
into the forecasting model, can be used to detect high-
risk areas for outbreaks and, consequently, to develop ef-
fective targeted surveillance [8]. Accurate and reliable dis-
ease forecasting can be of tremendous value to public
health. However, analyses of multi-year comprehensive in-
fectious disease syndrome data have not been conducted
till date. We can be use number of suspected cases of de-
tailed certain infectious diseases of each syndromes to
early prevent and detect the outbreaks and epidemics
based this information.
The current study was performed with the aim of
describing the trends in the incidence of infectious
diseases using the SSS of the EWAR unit in Mongolia
from January 2009 to December 2017. In addition, we
assessed the magnitude change in the occurrence fre-
quencies of these diseases and forecasted future inci-
dence trends.
Methods
Study design
This retrospective descriptive multi-year analytical study
utilized data on infectious disease syndromes from the
EWAR unit, as reported from January 1, 2009 to December
31, 2017. This study was part of the departmental data
review process in the EWAR unit of the Department
of Surveillance and Prevention of Infectious Disease
at the NCCD. Although no personal identifiers were
involved and no individuals stood to be jeopardized
by the study, institutional research guidelines follow-
ing the study approval were adhered to ensure scien-
tific soundness.
Collected data
As this study analyzed syndromic surveillance data from
all family health centers in 363 sub-provinces and sub-
districts at the primary level that were transmitted
through health departments and general hospitals in 21
provinces and public health centers and general
hospitals in nine districts in the capital city, as well as
syndromic surveillance data collected from tertiary state
central hospitals, specialized centers, regional diagnostic
and treatment centers, maternal hospitals, and other
large private hospitals at the tertiary level, all located in
the capital city. The primary and secondary levels
surveillance units such as public health facilities (84%)
and private hospitals (16%) that are a part of the national
surveillance system for infectious disease syndrome, the
data are representative of the national syndromic
surveillance situation, subject to reporting rates from all
health institutions; therefore, no sample size estimates
are required.
Data were collected from national surveillance system
through the EWAR 2.0 electronic database weekly feed-
back, which is sent to all surveillance units including all
family health centers, health departments and public and
private hospitals in 21 provinces and 9 districts in
Ulaanbaatar city. It includes the number of cases for
each of the eleven ID syndromes, seven suspected cases,
and four special events.
For this study, data on the five most prevalent infec-
tious disease syndromes: AFR, AFVR, AJ, AWD, ABD
and two special events (FD and NI) of the 22 infectious
disease syndromes were analyzed. Data pertaining to two
types of ARI syndromes: ARI influenza and ILI, and
ALRI were excluded because they have been reported
separately using the sentinel surveillance system since
2009, so there may be overlaps and underreporting in
the SSS. In addition, data on rare events with an inci-
dence < 1/10,000 population per year such as in the case
of AFP, AHS and ANS, the seven suspected cases and
two special events were not analyzed.
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Statistical analyses
Time trend analysis for incidence involved the following
seven prevalent infectious disease syndromes: AFR,
AFVR, AJ, AWD, ABD syndromes, and two special
events (i.e., FD and NI). Incidence was calculated from
the total number of syndromes of infectious diseases di-
vided by the total of the specific population multiplied
by 10,000. Time trend in the annual incidence of infec-
tious disease syndromes were assessed by Poisson log-
linear regression model with scaled standard errors to
deal with overdispersion. Year was considered independ-
ent variable, with annual incidence rate as dependent
variables. We conducted time series forecasting consid-
ering seasonality. We detected trend and seasonality of
the time series by visualizing the incidence rate of syn-
drome over time and using autocorrelation function
(ACF). As a result, we found that AFVR, AJ, AWD,
ABD, FD, and NI had seasonality, and they were pre-
dicted considering seasonality. Prospective time series
forecasting in the incidences of infectious disease syn-
dromes was conducted by Auto-Regressive Integrated
Moving Average (ARIMA) models or additive seasonal
exponential smoothing method until December 2020.
Before fitting models, if the variance of incidence rate
data was not stationary over time, the variance was
stabilized by log transformation. For forecasting AFR,
AFVR, AJ, AQD and ABD, seasonal ARIMA models
were applied in accordance with Box-Jenkins approach,
which consist of three steps: model identification, par-
ameter estimation, and model checking. Seasonal
ARIMA model was identified with ACF plot, PACF plot,
and Akaike information criterion. Portmanteau test was
used for checking autocorrelation in residuals. Statistical
analyses were performed using SAS (version 9.4, SAS
Inc., Cary, NC, USA) and R package, version 3.4.4 (The
R Foundation for Statistical Computing, Vienna,
Austria). Statistical significance was set as p < 0.05.
To test the rate trend per year, Poisson regression
model was estimated. In Poisson regression model, inci-
dence rates were calculated as numbers per unit time
given by the formula: Explanatory variable Log(E(Y/x)) =
α + βx, where Y is the average rate of events for a given
time (dependent variable) and α is the mean of Y, β-pre-
dictor value, and x - predictor variables (independent
variable). In our study, dependent variable was the an-
nual incidence rate, and independent variable was year.
Forecasting future trends in the incidences of syn-
dromes based on the data up to 2017 were assessed until
December 2020 using SAS (version 9.4).
Results
Incidence and prevalence of infectious disease syndromes
The nationwide overall prevalence of all infectious dis-
ease syndromes was 71.8 per 10,000 population between
2009 and 2017. The average number of all infectious
disease syndromes was 14,519 (range 5229 to 55,132)
per year. The five most prevalent infectious disease
syndromes, accounting for 96.4% of all the reported
cases were: AFR (38.7%), AFVR (31.7%), AJ (13.9%),
ABD (10.2%), and AWD (1.8%). The average number of
cases with the seven major syndromes was 14,687 (range
4070 to 54,522) per year. The average incidence rate of
the seven major infectious disease syndromes was 9.2
(0.04–34.5) per 10,000 population.
The incidence of AFR was the highest in 2016 (49.4%,
range 36,256/73,393), and lowest in 2009 (0.2%, range
163/73,393). The incidence of AFVR was the highest in
2017 (32.7%, range 19,659/60,082) and lowest in 2009
(0.9%, range 551/60,082). The highest prevalence of AJ
was reported in 2011 (32%, range 8441/26,383) while the
lowest was recorded in 2016 (2.5%, range 668/26,383).
The highest prevalence of AWD was reported in 2017
(16.7%, range 585/3507) while the lowest was recorded
in 2011 (7.7%, range 271/3507). The highest prevalence
of ABD was reported in 2017 (25.8%, range 5028/19,476)
while the lowest was recorded in 2009 (3%, range 593/
19,476). The highest prevalence of FD was reported in
2016 (25.5%, range 427/1675) while the lowest was re-
corded in 2009 (1.4%, range 23/1675). The highest
prevalence of NI was reported in 2011 (19.2%, range 64/
333) while the lowest was recorded in 2009 (4.8%, range
16/333).
Poisson regression analyses showed statistically signifi-
cant increase of incidence rate for AFR (p = 0.0162),
AFVR (p < 0.001), ABD (p < 0.001), and FD (p = 0.0015).
Incidence rate ratios (95% CI) for AFR, AFVR, ABD,
and FD were 1.599 (1.091, 2.344), 1.459 (1.393, 1.528),
1.288 (1.217, 1.363), and 1.201 (1.072, 1.344), respect-
ively. Incidence rates of AJ, AWD, and NI were not
significantly changed (Table 1).
Table 1 shows the annual incidence r1ates of the seven
syndromes between 2009 and 2017. The most prevalent
syndromes were AJ between 2009 and 2012 (59.5–
48.7%), AFVR between 2013 and 2014 (54.5–59%), AFR
during 2015 and 2016 (67.6–65.9%), and AFVR in 2017
(62.2%), as shown in Table 1.
Time series analysis and forecasting for infectious
diseases syndromes
Forecasting models for AFR, AFVR, AJ, AWD, and ABD
were ARIMA(1,0,1), ARIMA(0,1,1,)(0,1,1)12, ARIMA(0,1,
1)(0,1,1)12, ARIMA(1,1,1)(1,1,1)12, ARIMA(1,1,1)(1,1,1)12,
respectively (Table 2). For forecasting FD and NI, additive
seasonal exponential smoothing methods were applied.
Figure 1 presents the monthly time series data for
infectious diseases syndromes in Mongolia from 2009
to 2017.
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The highest prevalence rate (37.7 ± 6.1 cases monthly)
of AFR syndrome in 2015–2016 could be related to the
measles outbreak in Mongolia during 2015–2016. Ac-
cording to currently available data, there is a likelihood
that the outbreak started before March 2015, so the gen-
eral timeline trend in the incidence of AFR syndrome
for 2009–2017 was significantly increased during the
study period and prospective time series forecasting pre-
dicted a continuous stable trend in future years (Fig. 1a).
The incidence rate of AFVR showed winter’s multi-
plicative seasonal fluctuations with a peak at 10.6 ± 2
cases per 10,000 people in 2017. The highest incidence
was observed during autumn and spring every year. The
general timeline trend in the incidence of AFVR may
have risen significantly over the study period, with pro-
spective time series forecasting showing a continuous
rising trend in future years (Fig. 1b). The forecast for
AFVR was assessed until the end of 2018, because the
forecast for AFVR was too sensitive to the increasing
trend near the end of 2017, and resulted in unreasonable
forecast in long-term forecasting.
There were outbreaks related to AJ between 2010 and
2012, most likely due to hepatitis A outbreaks. The high-
est incidence of AJ was 5.5 ± 1 per 10,000 population in
the Winter’s multiplicative model. The general timeline
trend in the incidence of AJ did not show significant
change over the study period, while prospective time
series forecasting showed a continuous decreasing trend
in future years (Fig. 1c).
The AWD incidence rate showed simple seasonality
and roughly seasonal fluctuations from spring to au-
tumn, particularly May to October, with a peak of 0.5 ±
0.1 cases per 10,000 population in 2010. General time-
line trends in the incidence of the syndrome were con-
sistent during the study period, with prospective time
series forecasting showing continuous consistency with
seasonality in future years (Fig. 1d). This syndrome was
found to have simple seasonality, and roughly seasonal
fluctuations that slowly increase in spring and decrease
in autumn every year, particularly from May to October,
with a peak of 2.9 ± 0.6 cases per 10,000 population.
General timeline trends in the incidence of ABD
showed a slight annual increasing trend during the study
period, and prospective time series forecasting showed a
continuous rising trend in future years (Fig. 1e).
The incidence rate of FD showed simple seasonality
with irregular fluctuations, with a peak of 0.4 ± 0.1 cases
per 10,000 population in 2017. The highest incidence
rates of FD cases were reported in 2010, 2014, and 2016.
General timeline trends showed significant rising trend
during the study period, and prospective time series
forecasting showed a consistency with seasonality in
future years (Fig. 1f ).
The incidence rate of NI showed simple seasonality
with irregular fluctuations, and a peak of 0.07 cases per
10,000 population. The highest incidence rates were ob-
served in 2009, 2011 and 2017, with the highest number
of cases being reported in 2017. General timeline trends
showed no difference trend in the incidence of NI
Table 1 Annual trends in the incidence of major infectious disease syndromes by year in Mongolia, 2009–2017
Syndromes Annual incidence and proportion, cases/10,000 population (%) P value
2009 2010 2011 2012 2013 2014 2015 2016 2017
AFR 0.6(4) 1.1(3.8) 1.8 (4.1) 3.2 (8.8) 2.8 (7.5) 3.6 (9.6) 91.7 (67.6) 116.2 (65.9) 17.1 (16.8) 0.0162
AFVR 2 (13.4) 3.7 (12.9) 7 (16.3) 7.9 (21.5) 20.1 (54.5) 22.2 (59) 26.9 (19.9) 44.3 (25.1) 63 (62.2) < 0.001
AJ 9 (59.5) 17.4 (60.3) 30 (69.6) 17.8 (48.7) 6.9 (18.7) 3.7 (9.9) 3.5 (2.6) 2.1 (1.2) 2.2 (2.2) 0.1416
AWD 1.2 (7.7) 1.8 (6.4) 0.9 (2.2) 1.3 (3.6) 0.9 (2.5) 1.1 (2.9) 1.6 (1.2) 1.2 (10.7) 1.9 (1.9) 0.143
ABD 2.2 (14.4) 4 (13.9) 2.7 (6.2) 5.9 (16.2) 5.6 (15.1) 6.2 (16.5) 11.1 (8.2) 10.9 (6.2) 16.1 (15.9) < 0.001
FD 0.1 (0.6) 0.7 (2.4) 0.4 (1.0) 0.4 (1) 0.5 (1.4) 0.7 (1.8) 0.7 (0.5) 1.4 (0.8) 0.8 (0.8) 0.0015
NI 0.06 (0.4) 0.07 (0.2) 0.23 (0.5) 0.12 (0.3) 0.16 (0.4) 0.1 (0.3) 0.1 (0.1) 0.15 (0.1) 0.14 (0.1) 0.1995
AFR acute fever with rash, AFVR acute fever with vesicular rash, AJ acute jaundice, AWD acute watery diarrhea, ABD acute bloody diarrhea, FD foodborne disease,
NI nosocomial infection
P-values are tested for trend test. Incidences are calculated by cases /10,000 population, and proportions are expressed as % of the syndrome among total
reported cases. Underlined text shows the highest incidence of the year
Table 2 Forecasting models for infectious diseases syndromes
in this study
Infectious diseases syndromes Forecasting models
AFR ARIMA(1,0,1)
AFVR ARIMA(0,1,1,)(0,1,1)12
AJ ARIMA(0,1,1)(0,1,1)12
AWD ARIMA(1,1,1)(1,1,1)12
ABD ARIMA(1,1,1)(1,1,1)12
FD Additive seasonal exponential
smoothing method
NI Additive seasonal exponential
smoothing method
AFR acute fever with rash, AFVR acute fever with vesicular rash, AJ acute
jaundice, AWD acute watery diarrhea, ABD acute bloody diarrhea,
FD foodborne disease, NI nosocomial infection, ARIMA Auto-Regressive
Integrated Moving Average
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during last 9 years, with prospective time series
forecasting showing continuous consistency in future
years (Fig. 1g).
The observed data of 2018 and 2019 are also presented
within Fig. 1. For AFR, AFVR, AJ, ABD, and NI, the ob-
served incidences were within the 95% confidence limits
of forecasted data. For AWD and FD, there were some
sporadic time points with observed incidences higher
than 95% confidence limits of forecasted data.
Discussion
This study assessed the trends in the incidence of
infectious disease syndromes using an SSS, from 2009 to
2017, in Mongolia, and performed probabilistic time
series forecasting of infectious disease syndromes. Retro-
spective time series analysis showed positive trends in
the incidence of AFR, AFVR, ABD, and FD. An assess-
ment was performed using winters’ multiplicative sea-
sonality model for AFVR and AJ, simple seasonal
dynamics for AWD and ABD, and simple seasonality
with irregular fluctuations for FD and NI during the
study period. Prospective time series forecasting for
AFVR and ABD showed a continuous increasing trend,
while that for AJ showed a declining trend.
In addition, we observed a slightly increasing trend in
the incidence of AFR, AFVR, ABD, and FD over the years
since 2009; this may coincide with the duration of the im-
plementation of the SSS and is likely associated with the
increased distribution of data reporting and feedback at all
levels during the last nine consecutive years.
AFR syndrome was the most dominant syndrome in
Mongolia, at 37.7 ± 6.1 cases monthly, during the study
Fig. 1 Time series analysis of the monthly number of reported cases with infectious disease syndromes in Mongolia from Jan 2009 to Dec 2017
and forecasting the trends up to Dec 2020. a. Acute fever with rash b. Acute fever with vesicular rash c. Acute jaundice d. Acute watery diarrhea
e. Acute bloody diarrhea f. Foodborne disease g. Nosocomial infection. AFR, acute fever with rash; AFVR, acute fever with vesicular rash; AJ, acute
jaundice; AWD, acute watery diarrhea; ABD, acute bloody diarrhea; FD, foodborne disease; NI, nosocomial infection . Horizontal axis is the month
for measurement, and vertical axis is the incidence rate of reported cases by 10,000 population, as indicated. Forecasting models for AFR, AFVR,
AJ, AQD, ABD, FD, and NI are ARIMA(1,0,1), ARIMA(0,1,1,)(0,1,1)12, ARIMA(0,1,1)(0,1,1)12, ARIMA(1,1,1)(1,1,1)12, ARIMA(1,1,1)(1,1,1)12, additive seasonal
exponential smoothing method, and additive seasonal exponential smoothing method, respectively. Circles are actual data, and solid line shows
forecasted data. Dotted lines indicates the time point at which the observed (left of the dotted line) and predicted (right of the dotted line)
values are divided. Gray zone shows the 95% confidence limits.. The forecast for AFVR was assessed until the end of 2018, because the forecast
for AFVR was too sensitive to the increasing trend near the end of 2017, and resulted in unreasonable forecast in long-term forecasting
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period. Generally, this includes infectious diseases such
as measles, rubella, scarlatina, erythema, typhoid, dengue
fever, tick borne rickettsia, and tick borne borreliosis.
The trend in the incidence of AFR showed a low
prevalence rate from 2009 to 2015 followed by a surge
in the number of cases, corresponding to measles out-
breaks not only in Mongolia but also in neighboring
countries and others (China and South Korea) in 2015–
2016 [9, 10]. Measles is a highly contagious viral disease
that, despite the presence of a safe, effective and afford-
able vaccine that can prevent the disease for more than
40 years, remains a dominant cause of childhood death
in many countries [11].
The successful implementation of the 2003 World
Health Organization (WHO) Western Pacific Regional
Office (WPRO) measles targets through the strength-
ened National Immunization Program (NIP) dramatic-
ally decreased the measles-related morbidity and
mortality in 2012. However, during 2013–2015, the mea-
sles virus re-emerged in endemic countries, spreading to
countries in which the measles prevalence had decreased
through control [12].
In Mongolia, about 20 outbreaks had been registered
since 1958 with the most recent major outbreak occur-
ring in 2001. Mongolia was one of the four countries in
the WHO Pacific region that was certified as being mea-
sles-free in July 2014. However, on March 18, 2015 the
first registered case of the disease was reported in the
Chingeltei District of Ulaanbaatar city, with laboratory
testing showing viral genotype characteristics that were
similar to those of a strain circulating in China. The out-
break was attributed to the presence of imported mea-
sles virus. The outbreak occurred in two waves, with the
peak of the first wave occurring in May 2015 and the
second in February 2016, with about 50,000 suspected
measles cases. The number of measles-related deaths in-
creased in the second wave, coinciding with the preva-
lence of seasonal ILI due to high exposure from
hospitalizations during the incubation period of measles
in healthcare facilities. In terms of age, the most affected
populations were infants who were ineligible for the first
dose of the measles vaccine at 9 months of age and those
aged 18–30 years. About 74% of all measles-related
deaths occurred in children aged younger than 9months
who were previously non-immunized against measles.
Response measures undertaken included additional
two-dose anti-measles immunization with a coverage
of 88–93.4% of the target population aged younger
than 35 years old; these included infants aged 0–6
months who were immunized with the “0” dose of
the measles vaccine in high-density populations and
measles hotspots in five provinces in Mongolia.
The incidence of AFVR syndrome, which includes ill-
nesses such as chickenpox, and Enterovirus and Varicella
zoster virus infections, showed a 31-fold increase during
the study period. In Mongolia, hand, foot and mouth
disease showed the highest prevalence in May 2008 with
a prolonged period of presence lasting 2–3 years marked
by increments in spring and decreases in autumn, peak-
ing for 5–6months. About 6051 cases of the syndrome
were reported in 2017, indicating a surge in the number
of cases compared to previous years.
AJ syndrome comprises diseases such as hepatitis A-
E, leptospirosis and yellow fever. The occurrence of AJ
related to a hepatitis A outbreak between 2010 and
2013, then promptly have introduced vaccine against
hepatitis A virus (HAV) in the routine immunization
schedule in the NIP for first dose in 9 months then sec-
ond dose in 2 year olds starting in 12 provinces and
Ulaanbaatar city since 2012. As a result, the reported
number of HAV cases sharply dropped by 3.3 times as
of October 2013 compared to the prevalence in the pre-
vious five years. In addition, more than 77% of the
Mongolian population is estimated to have had hepa-
titis B virus (HBV) infection at some point, and be-
tween 10 and 22% of the general population has
chronic HBV infection. Hence, liver cancer is the single
most common cause of mortality – with one of the
highest rates worldwide and six times higher than the
global average [13]. In addition, hepatitis virus C treat-
ment was introduced in 2016 while hepatitis B vaccin-
ation was expanded when entry-level workers new
entering workers and other risk groups.
Early epidemic prediction is an important part of pub-
lic health, since current trends are assessed to provide
information on the future. Accurate and reliable
forecasts with sufficient lead times may provide greater
opportunities for disease control and offer effective re-
sponses to reduce the substantial morbidity and mortal-
ity related to these diseases. Early prediction can help in
planning, especially during outbreaks, and provide valu-
able information to decision-makers and experts in other
fields by indicating how far an outbreak is from being
under control.
In this study, prospective time series forecasting
demonstrated a potential increase in the incidence of
AFVR and ABD in future years in Mongolia. Relevant
specific diseases include hand, foot and mouth disease,
shigellosis are like gastrointestinal diseases. Factors that
may have contributed to the incidence of gastrointestinal
infectious diseases include poor food and water safety,
inadequate sanitation, and poor personal hygiene. Other
factors include a lack of inter-sector information sharing,
surveillance, response, preparedness, risk assessment,
risk communication, monitoring and evaluation, and in-
adequacies in the number of trained workers and labora-
tory capacity. Further efforts should focus on the
prevention of major disease outbreaks.
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The use of SS has increased, worldwide, in recent
years. A number of SS approaches have been proposed
and the types of SS have become increasingly diverse. SS
utilizes various information sources and the usage fre-
quency of each type varies depending on each country’s
medical practices. According to a US survey, 84% of the
43 public health departments conducting syndromic
surveillance included surveillance for emergency depart-
ment visits [14]. This was followed by surveillance for
outpatient department visits (49%), surveillance for over-
the-counter (OTC) medication sales (44%), and surveil-
lance for school absenteeism (35%), as of 2007. In
France, ILI surveillance is performed in 11,000 pharma-
cies within 21 regions across the country (about 50% of
all pharmacies in France) [15]. This ILI surveillance sys-
tem is a web-based system that collects medication sales
and weekly office visit data to provide influenza outbreak
forecasts using a Poisson regression model. In Japan, the
National Institute of Infectious Diseases has developed
an SSS based on the Early Aberration Reporting System
syndrome categories and software to analyze OTC sales
data, outpatient visit data, and ambulance transfer data
in Tokyo [16]. Approximately 5000 sites nationwide in
Japan are now connected to this system. In Mongolia, in
the past few years, surveillance has been conducted for
school absenteeism associated with acute respiratory in-
fection in selected schools during the flu season. In
addition, there is surveillance for factors such as human
immunodeficiency virus (HIV) infection, tuberculosis,
and immunization.
Previous studies have shown the usefulness of SS. In a
previous survey study, 80 and 92% of the respondents
reported that SS for influenza was “highly useful” and
“somewhat useful” as compared to other methods for
small outbreak detection [17]. Hence, most major coun-
tries use an SSS for ILI. For instance, SS for ILI with
respiratory symptoms is conducted in Taiwan, ILI with
respiratory symptoms and gastrointestinal symptoms in
Britain and France, and ILI with gastrointestinal symp-
toms and other specific symptoms in Australia. In South
Korea, 120 emergency departments from 16 provinces
and cities are now connected to the Korea Emergency
Department Information System for the daily analysis of
acute respiratory syndrome [17]. In the US, estimated
data obtained from Google Flu Trends and surveillance
for prescription medication showed a strong positive cor-
relation, and the number of searches containing the terms
“influenza” or “flu” was strongly to the percentage of influ-
enza-positive cases in clinical tests and deaths attribut-
able to pneumonia and seasonal influenza (https://
www.google.org/flutrends/about/). In Mongolia, influ-
enza and ILI, and ARI are monitored separately by
sentinel surveillance systems that include laboratory
confirmation.
This study has a number of limitations. First, data
were collected from weekly SSS feedback for the retro-
spective analysis, and due to multiple-type sources in-
cluding Excel, Word and PDF files, data omission and
incompleteness or the presence of errors cannot be ruled
out. Data quality evaluations for the detection of
reporting errors are critical for such surveillance data.
Second, it was difficult to verify underreporting or over-
reporting, and misdiagnosis or misclassification of the
syndromic diseases in the SSS database, as data for this
study included only pre-diagnostic clinical-based infor-
mation without laboratory confirmation. Third, we could
not consider the outbreak of hepatitis A and measles
during study period for developing forecasting models of
AJ and AFR. Fourth, the performance of long-term fore-
casting of some ARIMA models might be unreasonable.
Because the forecast for AFVR seems to be too sensitive
to the increasing trend near the end of 2017, we cut the
forecast for AFVR at the end of 2018. Finally, we could
not evaluate the accuracy of the diagnoses because we
did not obtain detailed information on demographics
and diagnoses through medical records.
Conclusions
This study shows the time series trends for infectious
disease syndromes in Mongolia. The surveillance system
for infectious disease syndromes can be useful in
providing an understanding of the current situation and
forecasting the future trends of various infectious
diseases. Prospective time series forecasting in the inci-
dence of AFVR and ABD showed increasing trends,
while the incidence rate for AJ showed a declining trend
in Mongolia. This study provides important information
on the pattern of infectious diseases in Mongolia.
Further research should analyze and estimate potential
forecasts using early warning signals provided for
particular diseases especially during outbreaks.
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